02/20/2026
The FDA has approved AstraZeneca’s Calquence (acalabrutinib), for adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). ➡️ https://hubs.li/Q04426zY0
CONTRACT PHARMA is the only worldwide publication focused on Bio/Pharma contract services, delivering a total qualified circulation of 20,026.
Montvale, NJ
07645
Be the first to know and let us send you an email when Contract Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.